{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T06:23:42Z","timestamp":1781504622786,"version":"3.54.1"},"reference-count":102,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.atherosclerosis.2010.11.039","type":"journal-article","created":{"date-parts":[[2010,12,6]],"date-time":"2010-12-06T10:50:13Z","timestamp":1291632613000},"page":"23-29","source":"Crossref","is-referenced-by-count":90,"title":["The relationship of vitamin D deficiency to statin myopathy"],"prefix":"10.1016","volume":"215","author":[{"given":"Ankur","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"June (2)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0005","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.atherosclerosis.2009.11.033","article-title":"The genetics of statin-induced myopathy","volume":"210","author":"Ghatak","year":"2010","journal-title":"Atherosclerosis"},{"issue":"January (3)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0010","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/jama.2008.939","article-title":"Researchers worry about myopathy risk for patients taking high-dose simvastatin","volume":"301","author":"Mitka","year":"2009","journal-title":"JAMA"},{"issue":"December (6)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0015","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.clpt.2006.09.003","article-title":"Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance","volume":"80","author":"Neuvonen","year":"2006","journal-title":"Clin Pharmacol Ther"},{"issue":"June (12)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0020","doi-asserted-by":"crossref","first-page":"858","DOI":"10.7326\/0003-4819-150-12-200906160-00009","article-title":"Narrative review: statin-related myopathy","volume":"150","author":"Joy","year":"2009","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0025","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2165\/00003088-200241050-00003","article-title":"Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors","volume":"41","author":"Williams","year":"2002","journal-title":"Clin Pharmacokinet"},{"issue":"April (13)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0030","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jama.289.13.1681","article-title":"Statin-associated myopathy","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"issue":"September (1)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0035","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/path.2018","article-title":"Statin therapy induces ultrastructural damage in skeletal muscle in patients without myalgia","volume":"210","author":"Draeger","year":"2006","journal-title":"J Pathol"},{"issue":"June (23)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0040","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2007.02.049","article-title":"The role of coenzyme Q10 in statin-associated myopathy: a systematic review","volume":"49","author":"Marcoff","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"December (6)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0045","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/MOL.0b013e3283168ecd","article-title":"Effects of ubiquinone (coenzyme Q10) on myopathy in statin users","volume":"19","author":"Schaars","year":"2008","journal-title":"Curr Opin Lipidol"},{"issue":"August (7)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0050","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1586\/14779072.6.7.971","article-title":"Statin myopathy as a metabolic muscle disease","volume":"6","author":"Phillips","year":"2008","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"March (3)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0055","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1194\/jlr.M600301-JLR200","article-title":"Effects of lipoprotein lipase and statins on cholesterol uptake into heart and skeletal muscle","volume":"48","author":"Yokoyama","year":"2007","journal-title":"J Lipid Res"},{"issue":"July (1)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0060","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clpt.2005.03.006","article-title":"High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial","volume":"78","author":"P\u00e4iv\u00e4","year":"2005","journal-title":"Clin Pharmacol Ther"},{"issue":"December (12)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0065","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1161\/01.ATV.0000190608.28704.71","article-title":"Changes in ubiquitin proteasome pathway gene expression in skeletal muscle with exercise and statins","volume":"25","author":"Urso","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"August (4)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0070","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/art.22100","article-title":"In vivo and in vitro characterization of skeletal muscle metabolism in patients with statin-induced adverse effects","volume":"55","author":"Guis","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"October (7)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0075","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.tcm.2004.08.003","article-title":"Selenoproteins, cholesterol-lowering drugs, and the consequences: revisiting of the mevalonate pathway","volume":"14","author":"Moosmann","year":"2004","journal-title":"Trends Cardiovasc Med"},{"issue":"January (1)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0080","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.atherosclerosis.2008.05.021","article-title":"Molecular basis of statin-associated myopathy","volume":"202","author":"Vaklavas","year":"2009","journal-title":"Atherosclerosis"},{"issue":"January (4)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0085","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/CIRCULATIONAHA.107.706127","article-title":"Vitamin D deficiency and risk of cardiovascular disease","volume":"117","author":"Wang","year":"2008","journal-title":"Circulation"},{"issue":"March (5)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0090","doi-asserted-by":"crossref","first-page":"315","DOI":"10.7326\/0003-4819-152-5-201003020-00010","article-title":"Systematic review: vitamin D and calcium supplementation in prevention of cardiovascular events","volume":"152","author":"Wang","year":"2010","journal-title":"Ann Intern Med"},{"issue":"September (9)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0095","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1111\/j.1532-5415.2009.02359.x","article-title":"Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults","volume":"57","author":"Ginde","year":"2009","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.atherosclerosis.2010.11.039_bib0100","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1359\/jbmr.1998.13.9.1360","article-title":"Receptors for 1,25(OH)2D3: past, present, and future","volume":"13","author":"Norman","year":"1998","journal-title":"J Bone Miner Res"},{"issue":"November\u2013December (6)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0105","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1562\/2004-11-19-RN-375","article-title":"Daily duration of vitamin D synthesis in human skin with relation to latitude, total ozone, altitude, ground cover, aerosols and cloud thickness","volume":"81","author":"Engelsen","year":"2005","journal-title":"Photochem Photobiol"},{"issue":"September","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0110","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/1471-2458-8-336","article-title":"Low wintertime vitamin D levels in a sample of healthy young adults of diverse ancestry living in the Toronto area: associations with vitamin D intake and skin pigmentation","volume":"8","author":"Gozdzik","year":"2008","journal-title":"BMC Public Health"},{"issue":"December (12)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0115","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.1210\/en.2003-1096","article-title":"Muscle: a nontraditional 1,25-dihydroxyvitamin D target tissue exhibiting classic hormone-dependent vitamin D receptor actions","volume":"144","author":"Demay","year":"2003","journal-title":"Endocrinology"},{"issue":"March (3)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0120","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1210\/jc.2007-2308","article-title":"Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D","volume":"93","author":"Holick","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"October (4)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0125","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/ajcn\/84.4.694","article-title":"The case against ergocalciferol (vitamin D2) as a vitamin supplement","volume":"84","author":"Houghton","year":"2006","journal-title":"Am J Clin Nutr"},{"issue":"October (4)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0130","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/ajcn\/68.4.854","article-title":"Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2","volume":"68","author":"Trang","year":"1998","journal-title":"Am J Clin Nutr"},{"issue":"September (9)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0135","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1373\/clinchem.2005.052936","article-title":"Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3","volume":"51","author":"Maunsell","year":"2005","journal-title":"Clin Chem"},{"issue":"August (2)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0140","doi-asserted-by":"crossref","first-page":"582S","DOI":"10.1093\/ajcn\/88.2.582S","article-title":"Pharmacokinetics of vitamin D toxicity","volume":"88","author":"Jones","year":"2008","journal-title":"Am J Clin Nutr"},{"issue":"July (2)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0145","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/ki.2010.17","article-title":"Vitamin D: a pleiotropic hormone","volume":"78","author":"Verstuyf","year":"2010","journal-title":"Kidney Int"},{"issue":"December (12)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0150","doi-asserted-by":"crossref","first-page":"5542","DOI":"10.1210\/en.2006-0946","article-title":"Minireview: vitamin D receptor: new assignments for an already busy receptor","volume":"147","author":"Norman","year":"2006","journal-title":"Endocrinology"},{"issue":"June (6)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0155","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.tem.2010.01.003","article-title":"Vitamin D: newly discovered actions require reconsideration of physiologic requirements","volume":"21","author":"Bikle","year":"2010","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2010.11.039_bib0160","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/978-0-387-77574-6_5","article-title":"Optimal serum 25-hydroxyvitamin D levels for multiple health outcomes","volume":"624","author":"Bischoff-Ferrari","year":"2008","journal-title":"Adv Exp Med Biol"},{"issue":"July (1)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0165","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/ajcn\/84.1.18","article-title":"Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes","volume":"84","author":"Bischoff-Ferrari","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.atherosclerosis.2010.11.039_bib0170","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1079\/BJN20051544","article-title":"Putting cardiovascular disease and vitamin D insufficiency into perspective","volume":"94","author":"Zittermann","year":"2005","journal-title":"Br J Nutr"},{"issue":"December (24)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0175","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.jacc.2008.08.050","article-title":"Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?","volume":"52","author":"Lee","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"August (8)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0180","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1161\/CIRCULATIONAHA.109.856070","article-title":"1,25(OH)2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus","volume":"120","author":"Oh","year":"2009","journal-title":"Circulation"},{"issue":"July (1\u20132)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0185","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jsbmb.2010.03.018","article-title":"Vitamin D regulates macrophage cholesterol metabolism in diabetes","volume":"121","author":"Riek","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"September\u2013October (2)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0190","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0021-9150(70)90111-5","article-title":"Effect of different doses of vitamin D on serum cholesterol and triglyceride levels in healthy men","volume":"12","author":"Carlson","year":"1970","journal-title":"Atherosclerosis"},{"issue":"June (1)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0195","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0378-5122(95)00909-5","article-title":"Does vitamin D3 have negative effects on serum levels of lipids? A follow-up study with a sequential combination of estradiol valerate and cyproterone acetate and\/or vitamin D3","volume":"22","author":"Tuppurainen","year":"1995","journal-title":"Maturitas"},{"issue":"November (5)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0200","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1530\/eje.0.1370495","article-title":"Long-term vitamin D3 supplementation may have adverse effects on serum lipids during postmenopausal hormone replacement therapy","volume":"137","author":"Heikkinen","year":"1997","journal-title":"Eur J Endocrinol"},{"issue":"September (9)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0205","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/ejcn.2009.18","article-title":"Vitamin D supplementation does not affect serum lipids and lipoproteins in Pakistani immigrants","volume":"63","author":"Andersen","year":"2009","journal-title":"Eur J Clin Nutr"},{"issue":"April (4)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0210","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3945\/ajcn.2009.28579","article-title":"Effect of 5 y of calcium plus vitamin D supplementation on change in circulating lipids: results from the Women's Health Initiative","volume":"91","author":"Rajpathak","year":"2010","journal-title":"Am J Clin Nutr"},{"issue":"January (1)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0215","first-page":"54","article-title":"Supplementation with calcium+vitamin D enhances the beneficial effect of weight loss on plasma lipid and lipoprotein concentrations","volume":"85","author":"Major","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.atherosclerosis.2010.11.039_bib0220","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1093\/jn\/123.6.1047","article-title":"Short-term dietary calcium fortification increases fecal saturated fat content and reduces serum lipids in men","volume":"123","author":"Denke","year":"1993","journal-title":"J Nutr"},{"issue":"March (3)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0225","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1079\/BJN2001508","article-title":"Effects of calcium and plant sterols on serum lipids in obese Zucker rats on a low-fat diet","volume":"87","author":"Vaskonen","year":"2002","journal-title":"Br J Nutr"},{"issue":"July (7)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0230","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1093\/jn\/135.7.1678","article-title":"Cholesterol metabolism is affected by calcium phosphate supplementation in humans","volume":"135","author":"Ditscheid","year":"2005","journal-title":"J Nutr"},{"key":"10.1016\/j.atherosclerosis.2010.11.039_bib0235","doi-asserted-by":"crossref","first-page":"957174","DOI":"10.1155\/2010\/957174","article-title":"Simvastatin does not affect vitamin d status, but low vitamin d levels are associated with dyslipidemia: results from a randomised, controlled trial","volume":"2010","author":"Rejnmark","year":"2010","journal-title":"Int J Endocrinol"},{"issue":"October (10)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0240","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1681\/ASN.V10102158","article-title":"Antagonistic effects of vitamin D and parathyroid hormone on lipoprotein lipase in cultured adipocytes","volume":"10","author":"Querfeld","year":"1999","journal-title":"J Am Soc Nephrol"},{"issue":"June (11)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0245","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/archinte.167.11.1159","article-title":"Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey","volume":"167","author":"Martins","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.atherosclerosis.2010.11.039_bib0250","doi-asserted-by":"crossref","first-page":"320721","DOI":"10.1155\/2010\/320721","article-title":"Vitamin d levels and lipid response to atorvastatin","volume":"2010","author":"P\u00e9rez-Castrill\u00f3n","year":"2010","journal-title":"Int J Endocrinol"},{"issue":"February (2)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0255","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/clpt.2008.165","article-title":"Effects of vitamin D supplementation in atorvastatin-treated patients: a new drug interaction with an unexpected consequence","volume":"85","author":"Schwartz","year":"2009","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0260","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1124\/mol.60.6.1399","article-title":"Transcriptional control of intestinal cytochrome P4503A by 1alpha,25-dihydroxy vitamin D3","volume":"6","author":"Thummel","year":"2001","journal-title":"Mol Pharmacol"},{"issue":"13","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0265","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.2165\/00003088-200342130-00005","article-title":"Clinical pharmacokinetics of atorvastatin","volume":"42","author":"Lennern\u00e4s","year":"2003","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0270","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/0006-291X(82)91118-4","article-title":"DNA synthesis and 3-hydroxy-3-methylglutarylCoA reductase activity in PHA-stimulated human lymphocytes: a comparative study of the inhibitory effects of some oxyterols with special reference to side chain hydroxylated derivatives","volume":"106","author":"Defay","year":"1982","journal-title":"Biochem Biophys Res Commun"},{"issue":"December (25)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0275","doi-asserted-by":"crossref","first-page":"14754","DOI":"10.1073\/pnas.2336107100","article-title":"A pathway for the metabolism of vitamin D3: unique hydroxylated metabolites formed during catalysis with cytochrome P450scc (CYP11A1)","volume":"100","author":"Guryev","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"October (8)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0280","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.amjcard.2007.05.024","article-title":"Statins and vitamin D","volume":"100","author":"Aloia","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2010.11.039_bib0285","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/0026-0495(91)90235-O","article-title":"Effects of pravastatin, a new HMG-CoA reductase inhibitor, on vitamin D synthesis in man","volume":"40","author":"Dobs","year":"1991","journal-title":"Metabolism"},{"issue":"September\u2013October (5)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0290","first-page":"427","article-title":"Effects of pravastatin and cholestyramine on circulating levels of parathyroid hormone and vitamin D metabolites","volume":"12","author":"Ismail","year":"1990","journal-title":"Clin Ther"},{"issue":"September\u2013October (5)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0295","first-page":"824","article-title":"Effects of pravastatin treatment on vitamin D metabolites","volume":"16","author":"Montagnani","year":"1994","journal-title":"Clin Ther"},{"issue":"September (40)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0300","first-page":"1254","article-title":"Iatropathogenic effect of Mevacor on vitamin D metabolism","volume":"128","author":"Wilczek","year":"1989","journal-title":"Cas Lek Cesk"},{"key":"10.1016\/j.atherosclerosis.2010.11.039_bib0305","first-page":"727","article-title":"Monitoring plasma levels of vitamin D metabolites in simvastatin therapy in patients with familial hypercholesterolemia","volume":"133","author":"Wilzcek","year":"1994","journal-title":"Cas Lek Cesk"},{"issue":"August (4)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0310","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10557-009-6181-8","article-title":"Increased levels of 25 hydroxyvitamin D and 1,25-dihydroxyvitamin D after rosuvastatin treatment: a novel pleiotropic effect of statins?","volume":"23","author":"Yavuz","year":"2009","journal-title":"Cardiovasc Drugs Ther"},{"issue":"April (7)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0315","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.amjcard.2006.11.036","article-title":"Effects of Atorvastatin on vitamin D levels in patients with acute ischemic heart disease","volume":"99","author":"P\u00e9rez-Castrill\u00f3n","year":"2007","journal-title":"Am J Cardiol"},{"issue":"March","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0320","article-title":"STATIN-D study: comparison of the influences of rosuvastatin and fluvastatin treatment on the levels of 25 hydroxyvitamin D","author":"Ertugrul","year":"2010","journal-title":"Cardiovasc Ther"},{"issue":"September (7)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0325","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/0898-6568(94)00042-5","article-title":"Non-genomic signal transduction pathway of vitamin D in muscle","volume":"6","author":"De Boland","year":"1994","journal-title":"Cell Signal"},{"issue":"November (6)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0330","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1097\/MCO.0b013e328331c707","article-title":"Vitamin D and its role in skeletal muscle","volume":"12","author":"Ceglia","year":"2009","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"November (5)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0335","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1172\/JCI109569","article-title":"Skeletal muscle calcium metabolism and contractile force in vitamin D-deficient chicks","volume":"64","author":"Pleasure","year":"1979","journal-title":"J Clin Invest"},{"issue":"November (4)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0340","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1210\/edrv-7-4-434","article-title":"Role of vitamin D in skeletal muscle function","volume":"7","author":"Boland","year":"1986","journal-title":"Endocr Rev"},{"key":"10.1016\/j.atherosclerosis.2010.11.039_bib0345","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0079-6107(68)90023-0","article-title":"Calcium ion and muscle contraction","volume":"18","author":"Ebashi","year":"1968","journal-title":"Prog Biophys Mol Biol"},{"key":"10.1016\/j.atherosclerosis.2010.11.039_bib0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0303-7207(95)03650-V","article-title":"Avian muscle cells as targets for the secosteroid hormone 1,25-dihydroxy-vitamin D3","volume":"114","author":"Boland","year":"1995","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0355","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/BF02405318","article-title":"Effects of vitamin D3 metabolites on calcium fluxes in intact chicken skeletal muscle and myoblasts cultured in vitro","volume":"36","author":"Giuliani","year":"1984","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0360","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0167-4889(89)90022-0","article-title":"Modulation of DNA synthesis in cultured muscle cells by 1,25-dihydroxyvitamin D-3","volume":"1014","author":"Drittanti","year":"1989","journal-title":"Biochim Biophys Acta"},{"issue":"September (9)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0365","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1359\/jbmr.1998.13.9.1353","article-title":"Identification of a membrane receptor for 1,25-dihydroxyvitamin D3 which mediates rapid activation of protein kinase C","volume":"13","author":"Nemere","year":"1998","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0370","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/jcb.10191","article-title":"1,25(OH)2-vitamin D3 induces translocation of the vitamin D receptor (VDR) to the plasma membrane in skeletal muscle cells","volume":"86","author":"Capiati","year":"2002","journal-title":"J Cell Biochem"},{"issue":"June (11)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0375","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.4161\/cc.8.11.8579","article-title":"Nuclear receptors: genomic and non-genomic effects converge","volume":"8","author":"Ord\u00f3\u00f1ez-Mor\u00e1n","year":"2009","journal-title":"Cell Cycle"},{"issue":"December (6)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0380","first-page":"435","article-title":"Reversible muscle weakness in patients with vitamin D deficiency","volume":"167","author":"Ziambaras","year":"1997","journal-title":"West J Med"},{"key":"10.1016\/j.atherosclerosis.2010.11.039_bib0385","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0140-6736(76)90428-1","article-title":"Muscle weakness in osteomalacia","volume":"1","author":"Schott","year":"1976","journal-title":"Lancet"},{"issue":"July (15)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0390","doi-asserted-by":"crossref","first-page":"8882","DOI":"10.1016\/S0021-9258(17)39433-4","article-title":"Identification of 1,25-dihydroxyvitamin D3 receptors and activities in muscle","volume":"260","author":"Simpson","year":"1985","journal-title":"J Biol Chem"},{"issue":"May (3)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0395","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1017\/S0317167100007083","article-title":"Severe proximal myopathy with remarkable recovery after vitamin D treatment","volume":"36","author":"Al-Said","year":"2009","journal-title":"Can J Neurol Sci"},{"issue":"June (6)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0400","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/mus.880170603","article-title":"Osteomalacic myopathy","volume":"17","author":"Russell","year":"1994","journal-title":"Muscle Nerve"},{"issue":"November (8)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0405","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/BF01705729","article-title":"Muscle weakness in intensive care patients: initial manifestation of vitamin D deficiency","volume":"20","author":"Rimaniol","year":"1994","journal-title":"Intensive Care Med"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0410","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/ki.1978.28","article-title":"Changes in the kinetics of muscle contraction in vitamin D depleted rats","volume":"13","author":"Rodman","year":"1978","journal-title":"Kidney Int"},{"issue":"August (8)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0415","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1001\/archinte.1992.00400200144028","article-title":"Can vitamin D deficiency produce an unusual pain syndrome?","volume":"152","author":"Reginato","year":"1992","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.atherosclerosis.2010.11.039_bib0420","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1210\/edrv-7-4-434","article-title":"Role of vitamin D in skeletal muscle function","volume":"7","author":"Boland","year":"1986","journal-title":"Endocr Rev"},{"issue":"March (3)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0425","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s001980200012","article-title":"Vitamin D and muscle function","volume":"13","author":"Pfeifer","year":"2002","journal-title":"Osteoporos Int"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0430","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000235874","article-title":"Treatment of vitamin D deficiency increases lower limb muscle strength in institutionalized older people independently of regular physical activity: a randomized double-blind controlled trial","volume":"54","author":"Moreira-Pfrimer","year":"2009","journal-title":"Ann Nutr Metab"},{"issue":"April (16)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0435","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1001\/jama.291.16.1999","article-title":"Effect of Vitamin D on falls: a meta-analysis","volume":"291","author":"Bischoff-Ferrari","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2010.11.039_bib0440","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s11926-005-0020-0","article-title":"Vitamin D: more than just affecting calcium and bone","volume":"7","author":"Staud","year":"2005","journal-title":"Curr Rheumatol Rep"},{"issue":"December (6)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0445","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.mam.2008.07.002","article-title":"Vitamin D and skeletal muscle tissue and function","volume":"29","author":"Ceglia","year":"2008","journal-title":"Mol Aspects Med"},{"issue":"February (2)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0450","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1042\/cs0560157","article-title":"Myopathy in bone loss of ageing: improvement by treatment with 1alpha-hydroxycholecalciferol and calcium","volume":"56","author":"S\u00f8rensen","year":"1979","journal-title":"Clin Sci (Lond)"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0455","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000087203","article-title":"Low-dose vitamin D prevents muscular atrophy and reduces falls and hip fractures in women after stroke: a randomized controlled trial","volume":"20","author":"Sato","year":"2005","journal-title":"Cerebrovasc Dis"},{"issue":"August (2)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0460","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.abb.2010.05.029","article-title":"Hypophosphatemia is responsible for skeletal muscle weakness of vitamin D deficiency","volume":"500","author":"Schubert","year":"2010","journal-title":"Arch Biochem Biophys"},{"issue":"December (6)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0465","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10557-005-5686-z","article-title":"Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients\u2014the PRIMO study","volume":"19","author":"Bruckert","year":"2005","journal-title":"Cardiovasc Drugs Ther"},{"issue":"December (12)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0470","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/qjmed\/hcp123","article-title":"Statin therapy, muscle function and vitamin D","volume":"102","author":"Goldstein","year":"2009","journal-title":"QJM"},{"issue":"July (1)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0475","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-2265.2008.03448.x","article-title":"Vitamin D insufficiency\u2014a novel mechanism of statin-induced myalgia?","volume":"71","author":"Lee","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"July (7)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0480","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/SMJ.0b013e3181e21088","article-title":"Resolution of statin-induced myalgias by correcting vitamin D deficiency","volume":"103","author":"Bell","year":"2010","journal-title":"South Med J"},{"issue":"April (8)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0485","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.amjcard.2006.11.071","article-title":"Fatal and widespread skeletal myopathy confirmed morphologically years after initiation of simvastatin therapy","volume":"99","author":"Boltan","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2010.11.039_bib0490","article-title":"Vitamin D levels are not related to myalgias in statin-treated patients with stable coronary disease","volume":"55","author":"Bittner","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"January (1)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0495","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.trsl.2008.11.002","article-title":"Low serum 25 (OH) vitamin D levels (<32ng\/mL) are associated with reversible myositis-myalgia in statin-treated patients","volume":"153","author":"Ahmed","year":"2009","journal-title":"Transl Res"},{"key":"10.1016\/j.atherosclerosis.2010.11.039_bib0500","unstructured":"Cholesterol Researcher Is Censured For Misrepresenting Data in Article By Lawrence K. Altman Published: July 18, 1987. Available at http:\/\/www.nytimes.com\/1987\/07\/18\/us\/cholesterol-researcher-is-censured-for misrepresenting-data-in-article.html [accessed 9\/28\/10]."},{"key":"10.1016\/j.atherosclerosis.2010.11.039_bib0505","doi-asserted-by":"crossref","DOI":"10.1161\/circ.118.suppl_18.S_470","article-title":"Abstract 3701: vitamin D deficiency is associated with myalgias in hyperlipidemic subjects taking statins","volume":"118","author":"Duell","year":"2008","journal-title":"Circulation"},{"issue":"April (4)","key":"10.1016\/j.atherosclerosis.2010.11.039_bib0510","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1359\/JBMR.0301257","article-title":"CYP3A4 is a human microsomal vitamin D 25-hydroxylase","volume":"19","author":"Gupta","year":"2004","journal-title":"J Bone Miner Res"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915010009780?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915010009780?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T13:40:42Z","timestamp":1740750042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915010009780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":102,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0021915010009780"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2010.11.039","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}